Access

Business

Nature 447, 899 (21 June 2007) | doi:10.1038/447899a; Published online 20 June 2007

Open Innovation Challenges

Anaemic outlook for Amgen

Top

A rash of problems has knocked some of the shine off one of the world's top biotechnology companies, as Meredith Wadman reports.

April may have been T. S.